ONCOLOGY VENTURES FUND I LP — Form D/A
ONCOLOGY VENTURES FUND I LP of NEW YORK, NY, a pooled investment fund, filed a Form D amendment with the SEC on 2024-05-14. The offering totals $40.0M, of which $21.2M was reported sold. Industry: Pooled Investment Fund.
Offering
- Filed: 2024-05-14
- Form: D/A
- Accession: 0001975143-24-000001
- Industry: Pooled Investment Fund
- Exemptions: 06b, 3C, 3C.7
- Total offering: $40.0M
- Amount sold: $21.2M
- Remaining: $18.8M
- Minimum investment: $10K
- Investors: 69
- Date of first sale: 2023-04-28
- Security types: fund interests
- Revenue range: Decline to Disclose
- SEC file number: 021-479913
Issuer
- Name: ONCOLOGY VENTURES FUND I LP
- CIK: 0001975143
- Entity type: Limited Partnership
- Jurisdiction: DELAWARE
- Incorporated: 2022
- Address: C/O ONCOLOGY VENTURES GP I LLC, NEW YORK, NY, 10002
- Phone: (516) 851-2311
Officers, directors & promoters (3)
| Name | Role | Location |
|---|
| Ben Freeberg | Executive Officer | Boca Raton, FL |
| N/A Oncology Ventures GP I LLC | Executive Officer | New York, NY |
| N/A Oncology Ventures LLC | Executive Officer | New York, NY |
Other filings by this issuer (2)
More